Ana Margarida Silva

Ana Margarida Silva

Auto-generated profile, based on publicly available information

Ana Margarida Silva

Serviço de Pediatria, Núcleo de Estudos da Função Respiratória, Sono e Ventilação do Departamento da Criança e da Família, Clínica Universitária de Pediatria, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte EPE, Lisboa

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2011 in Revista Portuguesa de Pneumologia
Verified
Journal Article
Open access
CCCarolina Constant
Carolina Constant
ISI. Sampaio
I. Sampaio
FNF. Negreiro
F. Negreiro
PAPedro Vargues Aguiar
Pedro Vargues Aguiar
ASA.M. Silva
A.M. Silva
TBT. Bandeira
T. Bandeira
ResumoIntroduçãoA exposição ao fumo do tabaco (EFT) é factor de risco para Doença Pulmonar Obstrutiva Crónica e um problema major de saúde pública. A EFT pré e/ou pós-natal determina redução precoce da função pulmonar e aumento da morbilidade respiratória, dependente da dose. Tem sido sugerido que a EFT domiciliária é influenciada por factores socioeconómicos.MétodosEstudo de rastreio epidemiológico transversal de dados de 313 crianças (52% rapazes) de 4 Escolas Básicas de Lisboa [1.° ano (54%) e 4.° ano]. A EFT e sintomatologia respiratória foram avaliadas a partir de questionário auto-preenchido pelos pais. Todas as crianças efectuaram espirometria na escola e 54% foram consideradas aceitáveis de acordo com critérios ATS/ERS. Efectuou-se análise descritiva e bivariada das variáveis com maior interesse e análise de regressão logística múltipla ajustada para as variáveis com significado clínico/estatístico.ResultadosEm 41% dos casos a criança convivia com fumadores no domicílio (EFT na gravidez 18%, mãe fumadora 32%, pai fumador 38%). Os pais fumadores tinham escolaridade inferior e ocupações menos qualificadas. Tosse foi mais frequente nas crianças com mãe fumadora (OR ajustado = 2,1 95%CI 1,1–4,0) e sibilância nas crianças com EFT na gravidez e com mãe/pai fumadores. Todas as diferenças foram significativas (p< 0,05). Não se encontrou associação entre educação parental e sintomatologia respiratória ou ETF e infecções respiratórias/asma/diminuição de valores espirométricos.ConclusãoA EFT é frequente em crianças em idade escolar em Lisboa e condiciona morbilidade respiratória significativa. Intervenções dirigidas devem ter em conta condições sociais. Neste estudo a espirometria de campo foi pouco útil na detecção precoce de diminuição da função pulmonar em crianças associada à EFT.AbstractIntroductionTobacco smoke is a risk factor for Chronic Obstructive Pulmonary Disease and a major public health problem. Prenatal maternal smoking and post-natal environmental tobacco smoke (ETS) lead to dose-dependent decrease in lung function and respiratory morbidity. Influence of different socioeconomic indicators and ETS in the home has also been suggested.MethodsData on 313 children (52% male) from 4 public schools in Lisbon was analyzed [1st (46%) and 4th graders]. ETS assessment and respiratory symptoms were based on a self-answered questionnaire. All children performed standard spirometry in the school setting and 54% were acceptable according to ATS/ERS criteria. Descriptive and bivariate analysis of the most relevant variables was done, followed by multiple logistic regression analysis adjusted to the variables with clinical/statistical relevance.ResultsETS in the home was found in 41% (maternal smoking during pregnancy 18%, smoking mother 32%, smoking father 38%). Smoking fathers had lower education and less qualified occupation. Cough was more frequent in children with a smoking mother (adjusted OR = 2.1 95CI 1.1–4.0) and wheezing in children with maternal smoking during pregnancy and smoking parents. All differences were significant (p<0.05). No association was found between parental education and cough/wheeze or ETS and respiratory infections/asthma/decreased spirometric values.ConclusionsChildren in Lisbon are frequently exposed to ETS which results in significant respiratory morbidity. Targeted interventions must have social conditions in consideration. In this study, field spirometry was not helpful in early detection of lung function disability in children associated with ETS

27 September 2021
Verified
Book Chapter
Closed access
PDF file
ISIsabel Silva
Isabel Silva
MCMariana Clemente
Mariana Clemente
CFCarla Ferreira
Carla Ferreira
ASAna Margarida Silva
Ana Margarida Silva
AGAntónio Gabriel
António Gabriel
Armando CaseiroArmando Caseiro
Armando Caseiro
Cholesterol is a long chain polycyclic alcohol, usually called a steroid, that plays several structural and metabolic roles vitals to human biology. Body cholesterol is derived from two sources, de novo biosynthesis and diet and its metabolism homeostasis depend on absorption, synthesis and excretion mechanisms. Aging is a physiological process influenced by the interaction of multiple endogenous and exogenous factors and the genetic component characterized by loss of homeostasis that leads to changes in the biochemical composition of tissues, reduced adaptive responsiveness to environmental stimuli and increased susceptibility to disease. Various aspects of cholesterol metabolism, including its synthesis and excretion, are compromised in aging. Several studies indicate that serum cholesterol levels increase in adulthood but tend to decrease in the older adult. A trend of increase plasma cholesterol with aging was observed, namely low-density lipoprotein cholesterol, however in very old age a decrease in total cholesterol was observed that was associated with poor health and multi-morbidity. Appropriate prevention of chronic conditions such as cardiovascular disease and associated risk factors in older patients is becoming increasingly important to enable sustainable health care and maintain quality of life. Age and plasma cholesterol concentration are well-recognized cardiovascular risk factors, together with the wide availability of safe and effective pharmacological cholesterol lowering agents is assumed that the treatment is highly recommended for the older population, providing significant protection in these individuals. However, in this population there are other aspects to consider, such as age-related changes in pharmacokinetic and pharmacodynamic properties of drugs. Direct experimental evidence is very limited, especially in the older strata of the population.